Journal of Neuroinflammation, 2021 · DOI: https://doi.org/10.1186/s12974-021-02337-2 · Published: December 1, 2021
Spinal cord injury (SCI) leads to loss of motor and sensory function. The initial trauma causes ischemia, oxidative damage, edema, and glutamate excitotoxicity. This starts a secondary injury cascade, which can last over 6 months, causing more cell death. Inflammation after SCI is complex, involving many cells and signaling molecules like TNFα, IL-1β, and IL-6. While inflammation has some positive effects, excessive immune cell infiltration contributes to neural degeneration. This review develops a timeline of immune cell and cytokine behavior after SCI in rodent models, highlighting differences between rats and mice. Understanding SCI pathophysiology is crucial for identifying effective therapeutic targets to reduce secondary damage.
Identify specific cytokines and immune cells to target for therapeutic intervention.
Develop treatments that address the specific inflammatory events occurring at different stages post-SCI.
Consider the differences in inflammatory responses between species when designing and testing new SCI therapies.